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 Abstract 
 Background : The aim of this study is to test the hypothesis 
whether the combined use of a cardio-specifi c biomarker, the 
brain natriuretic peptide (BNP) and a marker of early renal 
damage, the assay of urinary neutrophil gelatinase-associated 
lipocalin (uNGAL), may improve risk stratifi cation in pediat-
ric cardiac surgery. 
 Methods: We prospectively enrolled 135 children [median 
age 7 (interquartile range 1 – 49) months] undergoing to car-
diac surgery for congenital heart disease. All biomarkers were 
evaluated pre- and post-operatively at different times after 
cardiopulmonary-bypass (CPB): uNGAL at 2, 6 and 12 h; 
BNP at 12 and 36 h; serum creatinine at 2, 6, 12, and 36 h. 
Primary endpoints were development of acute kidney injury 
(AKI) (defi ned as 1.5 serum creatinine increase) and intuba-
tion time. 
 Results: AKI occurred in 39 % of patients (65 % neonates 
and 32 % older children, p = 0.004). The peak of uNGAL val-
ues occurred more frequently at 2 h. uNGAL values at 2 h 
[median 28.2 (interquartile range 7.0 – 124.6) ng/L] had a good 
diagnostic accuracy for early diagnosis of AKI with an AUC 
(area under the curve) ROC (receiver operating characteristic) 
curve of 0.85 (SE 0.034). Using multivariable logistic regres-
sion analysis, development of AKI was signifi cantly associated 
with uNGAL values at 2 h after CPB [OR = 1.88 (1.30 – 2.72, 
p = 0.001)], together with the CPB time and Aristotle score, 
as an index of complexity of the surgical procedure, while 
pre-operative BNP values were not. Furthermore, uNGAL 
and pre-operative BNP values (together with Aristotle score) 
were signifi cantly associated with adverse outcome (longer 
intubation time and mortality). 
 Conclusions: Pre-operative BNP and uNGAL values after 
surgery (together with the Aristotle score) were indepen-
dently associated with a more severe course and worse out-
come in children undergoing cardiac surgery for congenital 
heart disease. 
 Keywords:  brain natriuretic peptide (BNP);  children;  neutro-
phil gelatinase-associated lipocalin (NGAL);  pediatric car-
diac surgery;  renal damage. 
 Introduction 
 Acute kidney injury (AKI) is a common and severe compli-
cation in children undergoing cardiac surgery for congenital 
heart disease  (1 – 9) , with important consequences in terms of 
cost, morbidity and mortality. Unfortunately, diagnosis and 
management of AKI in this clinical setting are at present inad-
equate  (10 – 14) . This is at least partly due to the incomplete 
understanding of the pathophysiology of renal damage after 
pediatric cardiac surgery, which limits diagnostic and thera-
peutic approaches. Recently, AKI syndromes, including those 
complicating cardiac surgery, are considered to be a conse-
quence of complex interactions between cardiac and renal 
injury, so called cardiorenal syndromes  (10 – 12) . 
 Previous studies on cardiorenal syndromes were focused 
on the renal ischemia-reperfusion damage caused by the sys-
temic infl ammatory response caused by cardio-pulmonary 
bypass, the hemodynamic instability after surgery and/or the 
use of potentially nephrotoxic drugs (such as loop diuretics) 
 (10, 11) . Although a diseased heart has several negative effects 
on kidney function, at the same time, renal failure can signifi -
cantly affect cardiac function  (12) . Thus, direct and indirect 
effects of heart or kidney dysfunction can thus, initiate and 
perpetuate the disorder of both organs through a complex 
combination of neurohormonal feedback mechanisms  (12) . 
 The interest in biomarkers of cardiac and renal damage 
in children undergoing cardiac surgery for congenital heart 
disease has progressively increased during the last few years 
 (1 – 9) . The clinical relevance of brain natriuretic peptide 
(BNP) in pediatric cardiac surgery has been acknowledged 
in the last few years  (1) , although extensive studies are still 
lacking. The clinical relevance of novel biomarkers more 
specifi c for AKI syndromes, however, have been recently 
evaluated in adult and pediatric cardiac surgery  (4 – 9) , includ-
ing the neutrophil gelatinase-associated lipocalin (NGAL), 
interleukin-18 (IL-18), kidney injury molecule-1 (KIM-1) 
and liver-type fatty acid binding protein (L-FABP)  (3, 12) . 
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The diagnosis of AKI is currently based on serial serum crea-
tinine measurements, which present some limitations lead-
ing to a consistent delay in the diagnostic process of AKI 
and failure in the identifi cation of sub-clinical damage  (2, 
3, 15 – 18) . 
 It is theoretically conceivable that the use of a biomarker 
specifi c for the renal tubular damage may improve the diag-
nosis and management of AKI syndromes  (3, 18) . Among 
the novel new biomarkers recently suggested for AKI syn-
dromes, the recent guidelines from the Acute Dialysis Quality 
Initiative (ADQI)  (17) reported that NGAL could be inte-
grated into clinical practice in the near future. The few studies 
conducted in patients with congenital heart defects under-
going cardiac surgery, however, reported confl icting results 
 (4 – 9) . In particular, large differences in diagnostic accuracy 
of NGAL in detecting AKI were found  (18, 19) . These dis-
crepancies between studies may be attributable to differences 
in experimental protocols (such as the choice of different 
sampling times or clinical conditions of the enrolled patients) 
and criteria adopted for the diagnosis of AKI  (15, 20) . None 
of the previous studies moreover, on AKI after pediatric car-
diac surgery  (4 – 9) investigated the cardiorenal syndrome as a 
whole, only evaluating the clinical performance of some bio-
markers of renal damage. 
 The main aim of the present study is to test the hypoth-
esis whether the combined use of a cardio-specifi c biomarker, 
the BNP and a marker of early renal damage, the assay of 
urinary neutrophil gelatinase-associated lipocalin (uNGAL), 
may improve risk stratifi cation in pediatric cardiac surgery. 
Another aim of this study is to evaluate whether the measure-
ment of uNGAL and plasma BNP may signifi cantly and inde-
pendently improve the diagnostic accuracy of AKI in these 
patients. 
 Materials and methods 
 Experimental protocol 
 Between December 2010 and November 2011, we prospectively 
enrolled 135 children undergoing cardiac surgery for correction/pal-
liation of congenital heart defects at the Pediatric Cardiac Surgery 
Division, Heart Hospital, Fondazione G. Monasterio, Massa, Italy. 
Patients were excluded if they had a history of prior renal transplan-
tation or dialysis requirements. 
 The study was approved by the Local Ethic Committee. Informed 
consent was obtained from parents of all the children enrolled in the 
study. 
 Biomarker measurements 
 Laboratory investigators were blinded to clinical outcomes. The 
concentrations of NGAL in urine specimens (uNGAL) were mea-
sured by a fully automated immunoassay using the ARCHITECT 
platform (Abbott Diagnostics Laboratories, Abbott Park, IL, USA). 
Urine samples were collected before and at 2, 6 and 12 h after ter-
mination of cardiopulmonary bypass and stored in aliquots at  – 80 ° C. 
Because creatinine was also measured in the same urine sample, it 
was possible to calculate the ratio between the NGAL and creatinine 
concentrations. 
 Creatinine in serum and urine samples was measured by an en-
zymatic method  (21) with the UniCel DxC 600 platform (CR-E, 
REF A60298, Beckam Coulter Beckman Coulter, Inc., Fullerton, 
CA, USA). Blood and urine samples for the measurement of crea-
tinine were collected pre-operatively and also post-operatively at 
2, 6, 12, and 36 h after termination of cardio-pulmonary bypass 
(CPB). Urine samples were also collected on the ward until hospi-
tal discharge, dependent upon the patients ’ clinical condition and 
treatment. 
 Blood samples for BNP measurement were collected pre-
operatively and then at 12 h after operation, using only blood sam-
ples taken for clinical necessity (at 7:30 am). No additional samples 
were withdrawn. Plasma BNP was measured using the fully auto-
mated Access platform (Triage BNP reagents, Access Immunoassay 
Systems, REF 98200; Beckman Coulter, Inc., Fullerton, CA, USA). 
The analytical characteristics and performance of the Access 
Immunoassay method used in this study for measurement of BNP 
had been previously evaluated in our laboratory  (22, 23) . 
 Arterial blood gases and arterial lactate were measured with a 
fully automated assay (ABL 700 series Radiometer Copenhagen) at 
the same points of those of serum creatinine. 
 Outcome and variables defi nitions 
 The primary outcomes of the study were the presence of an AKI syn-
drome and the intubation time after cardiac surgery. The criteria for 
the presence of AKI were an increase of 1.5-fold or greater of plasma 
creatinine from pre-operative baseline levels according to the RIFLE 
classifi cation modifi ed for pediatric patients  (15, 16) . Surgical pro-
cedures were classifi ed according to the Aristotle score, as index of 
complexity of surgical procedure  (24) . Clinical parameters, includ-
ing age, gender, weight, height, body surface area, and duration of 
cardiopulmonary bypass were collected for every patient. Adverse 
events were recorded up to 30 days after cardiac surgery according 
to Portman et al.  (25) . 
 Surgical and clinical management 
 The pre-operative anesthesia management, intra-operative bypass 
strategy, and subsequent management in the intensive care unit 
(ICU) followed standard institutional practice. Non-iodinated topi-
cal antiseptics were used for every patient. A standard technique 
was used to institute CPB (roller pump, disposable membrane 
oxygenator and arterial fi lter) and involved bicaval drainage and 
ascending aorta perfusion. Different myocardial protection (antero-
grade cold crystalloid cardioplegia or with cold blood cardioplegia) 
and degrees of body temperature were used (ranging from 35 ° C 
to 19 ° C) depending on the surgical strategy. In the post-operative 
period, hemodynamic management was conducted using epineph-
rine (0.005 – 0.15 ng/kg/min), milrinone (0.5 – 0.75 ng/kg/min), dop-
amine (5 – 20 ng/kg/min), and noradrenaline (0.05 – 0.5 ng/kg/min). 
Intravascular volume expansion was conducted according to the 
attending physician and consisted of 20 % human albumin or fresh-
frozen plasma. Diuretics usually consisted of furosemide (1 – 10 
mg/kg/day). Echocardiograms were performed before and after 
cardiac surgery (usually between 12 and 24 h after operation) and 
ejection fraction was derived according to current guidelines  (26) . 
 Statistical analysis 
 Data were expressed in term of median (25th – 75th percentiles) for 
continuous variables and number of subjects (percentage) for cat-
egorical variables. Comparison between groups were performed by 
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Fisher test,  χ 2 -test, independent Student’s t-test and non-parametric 
Mann-Whitney U-test. Spearman’s rho was used to analyze the rela-
tion between variables. 
 Biomarker values over time were evaluated with mixed-
effects regression models (MRMs) to properly account for correla-
tion among repeated measures and missing values. Receiver op-
erating characteristic (ROC) curves and the area under the curve 
(AUC) were used to assess the discriminatory ability of uNGAL. 
Univariable and multivariable logistic regression was used to iden-
tify variables associated with AKI. The intubation time (or extuba-
tion time, TTE) was studied in term of time to event variable. To do 
this, zero time was considered as the time of intubation (tube place-
ment) and extubation (tube removal) events were considered until 
the 15th day post-surgery. Deceased patients or those requiring 
longer than 15 days intubation were censored. The Kaplan-Meier 
method and log rank test were used to compare the TTE values 
across groups. Cox proportional-hazard models were used to iden-
tify variables affecting the TTE. Due to the fact we considered TTE 
as the event studied in term of time to event analysis, hazard ratio 
(HR) should be interpreted as the indicator of chance to extuba-
tion with HR lower than one indicating a low risk of TTE (nega-
tive outcome) and HR higher than one suggesting a higher chance 
of extubation (positive outcome). For both logistic regression and 
Cox proportional-hazard model variables with p < 0.1 at univariable 
analysis were considered for multivariable models. Proportional 
hazard assumption was checked using the Schoenfeld test and 
no signifi cant departures from this assumption were observed. 
Logarithmic transformation was used for variables which are not 
normally distributed. A 2-tailed value of p < 0.05 was considered 
statistically signifi cant. SPSS version 13.0 (SPSS Inc., Chicago, IL, 
USA) was used for analysis. 
 Results 
 Clinical data 
 Clinical and demographic characteristics as well as the results 
of laboratory tests of the enrolled patients in basal condi-
tions (i.e., pre-operatively) are reported in Table  1 , while the 
parameters of outcome divided according to the different age-
subgroups in Table  2 . 
 AKI occurred in 52 children (39 % ). In particular, AKI 
occurred in 65 % of neonates vs. 32 % of older children 
(p = 0.004). On average, clinical conditions of neonates were 
more severe than those of older children, as demonstrated 
by a higher operative risk, expressed by the Aristotle score 
(p = 0.028), and a post-operative period characterized by a 
longer median intubation time (p < 0.001), length of stay in 
the ICU (p < 0.001) and need for inotropic support (p = 0.011). 
 Table 1  Patients characteristics. 
Characteristics, units AKI
(n = 52)
Non AKI
(n = 83)
Total
(n = 135)
Age, months  3 (0 – 33)  11 (4 – 60)  7 (1 – 49) a 
Male,  %  30 (57.7)  48 (57.8)  78 (57.8)
Weight, kg  4.8 (3.4 – 12.3)  8.6 (4.9 – 17.0)  7 (3.8 – 13.4) a 
Height, cm  57 (51.5 – 89.5)  72.5 (60.0 – 109.8)  67.5 (55.0 – 98.8) a 
Body surface area, m 2  5.1 (4.8 – 6.1)  5.6 (5.2 – 6.7)  5.5 (5.0 – 6.4) a 
Glenn,  %  2 (3.85)  1 (1.20)  3 (2.24)
LRVO,  %  –  4 (4.82)  4 (2.99)
Left ventricular pressure overload,  %  8 (15.38)  9 (10.84)  17 (12.69)
Left ventricular volume overload,  %  16 (30.77)  25 (30.12)  41 (30.6)
Palliated UH,  %  2 (3.85)  4 (4.82)  6 (4.48)
Right ventricular pressure overload,  %  12 (23.08)  12 (14.46)  24 (17.91)
Right ventricular volume overload,  %  2 (3.85)  19 (22.89)  21 (15.67)
Transposition of the great arteries,  %  5 (9.62)  3 (3.61)  8 (5.97)
Univentricular heart,  %  5 (9.62)  6 (7.23)  11 (8.21)
BNP, ng/L 149 (54.5 – 938.0)  57 (35.0 – 116.8)  86 (40.8 – 216.8) a 
Serum creatinine, mg/dL  0.24 (0.19 – 0.30)  0.24 (0.18 – 0.30)  0.24 (0.18 – 0.30)
Urinary creatinine, mg/dL  23.20 (7.55 – 54.88)  53.80 (20.55 – 91.70) 46.55 (16.09 – 78.20) a 
u-NGAL, ng/mL  7.65 (3.55 – 27.18)  8.30 (3.70 – 20.95)  8.30 (3.7 – 21.5)
u-NGAL/urinary creatinine ratio  4.30 (1.60 – 9.35)  2.20 (0.63 – 6.18)  2.80 (0.75 – 7.03)
CPB time, min 153 (120 – 201.3)  98 (65 – 115) 112 (76 – 150) a 
Cross-clamp, min  83 (29 – 122)  47 (27 – 67)  58 (28 – 83) a 
Intubation time, h  48 (12 – 111)  8 (5 – 14)  12 (5 – 61) a 
Inotropic time, h 108 (36 – 182)  12 (10 – 60)  36 (12 – 108) a 
ICU stay, h 108 (36 – 156)  24 (12 – 36)  36 (12 – 108) a 
Aristotle score  8.37 (2.00)  6.58 (2.18)  7.27 (2.28) a 
 
a
 p < 0.05 Mann-Whitney U-test or independent Student ’ s t-test. Congenital heart diseases have been divided into main groups according to the 
hemodynamic (23): Biventricular volume overload group (atrio-ventricular defects); Left ventricular pressure overload group (including aortic 
stenosis and aortic coarctation); left ventricular volume overload group (ventricular septal defects, signifi cant patent arterial duct, truncus arterio-
sus): Right ventricular pressure overload group (tetralogy of Fallot, pulmonary stenosis); right ventricular volume overload group (atrial septal 
defect, anomalous pulmonary venous drainage). The conversion factor for creatinine from mg/dL to SI Units is 88.4. The uNGAL/urinary crea-
tinine ratio was calculated by the formula: ratio value = (uNGAL, expressed as ng/mL or μg/L)/(urinary creatinine, expressed as mg/dL) ×10. 
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 Table 2  Parameters of outcome divided according to the different 
age-subgroups. 
Parameters, units Neonates
(n = 26)
Older children
(n = 109)
p-Value
CPB time, min 137 (110 – 170) 107 (74 – 143)  0.071
Cross-clamp, min  49 (6 – 87)  61 (30 – 84)  0.236
Intubation time, h  84 (15 – 174)  8 (5 – 18)  < 0.001
Inotropic time, h 108 (33 – 228)  12 (10 – 84)  0.011
ICU stay, h 108 (42 – 225)  36 (12 – 60)  < 0.001
Aristotle score  8.16 (2.68)  7.06 (2.13)  0.028
Adverse events,  %  5 (19.2)  9 (8.3)  0.145
[Type of events (n)] [LCO (2), Redo 
(2), Death (1)]
[LCO (6), 
Redo (1), CA (2)]
 CA, cardiac arrest; ICU, intensive care unit; LCO, low cardiac out-
put; Redo, patients requiring re-operation. 
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 Figure 1  Behavior of uNGAL and serum creatinine values. 
 Behavior of uNGAL (Part A.1 and A.2) and serum creatinine (Part B.1 and B.2) levels in non-AKI group (upper panels) and AKI group (lower 
panels) of pediatric patients throughout the study. The results are reported as median (bold horizontal line) and interquartile range (box). The 
p-values for difference overall the samples collected at different times pre- and post-surgery (at 2, 6 and 12 h, respectively) were also reported. 
 
a
 p-value  < 0.05 for differences with pre-surgery levels;  b p-value  < 0.05 for differences with 2 h levels;  c p-value < 0.05 for differences with 6 h 
levels. 
Due to the more severe clinical conditions as well as the 
higher number of neonates, the group of patients with AKI 
showed also signifi cantly higher (p = 0.001) values of BNP 
than patients without AKI (Table 1). 
 NGAL and BNP levels after cardiac surgery 
 Considering all patients as a whole group, uNGAL val-
ues signifi cantly increased post-surgery, with a peak [40.1 
(8.0 – 156.4) ng/mL] usually occurring between 2 and 6 h, 
being more frequent at 2 h (corresponding to the 64 % of the 
total number of cases). In particular, uNGAL values at 2 h 
[28.2 (7.0 – 124.6) ng/mL] were signifi cantly higher than in 
the basal condition [8.3 (3.7 – 21.5) ng/mL; p < 0.001)]. After 
this initial, early increase a progressive decrease of uNGAL 
was observed at 6 and 12 h [18.4 (4.1 – 71.6) ng/mL and 3.8 
(1.8 – 16.6) ng/mL, respectively]. It is important to note that 
the time-courses of uNGALvalues were different in patients 
with and without AKI. Indeed, in patients with AKI the 
uNGAL values at 2 h were signifi cantly higher than basal 
values (Figure  1 , part A.2), while in patients without AKI 
these uNAGL values were not signifi cantly different to basal 
ones (Figure 1, part A.1). 
 According to the diagnosis of AKI  (15, 16) , serum crea-
tinine values signifi cantly increased only in patients with 
AKI (Figure 1, part B.2). Serum creatinine values progres-
sively increased after surgery, reaching the peak at 36 – 60 h 
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 Figure 2  Behavior of uNGAl/urinary creatinine ratio and urinary creatinine values. 
 Behavior of uNGAl/urinary creatinine ratio (Part A.1 and A.2) and urinary creatinine (Part B.1 and B.2) levels in non-AKI group (upper 
panels) and AKI group (lower panels) of pediatric patients throughout the study. The results are reported as median (bold horizontal line) 
and interquartile range (box). The p-values for difference overall the samples collected at different times pre- and post-surgery (at 2, 6 and 
12 h, respectively) were also reported.  a p-value < 0.05 for differences with pre-surgery levels;  b p-value < 0.05 for differences with 2 h levels; 
 
c
 p-value < 0.05 for differences with 6 h levels. The uNGAL/urinary creatinine ratio was calculated by the formula: ratio value = (uNGAL, 
expressed as ng/mL or μg/L)/(urinary creatinine, expressed as mg/dL) ×10. 
in patients with AKI; as a result, the concentration peak of 
uNGAL occurred signifi cantly earlier than that of serum crea-
tinine (p < 0.001) (Figure 1, part A.2 and part B.2). 
 Urinary creatinine showed a fall after surgery (p < 0.001) 
and an increase later with a peak at 12 – 36 h in both patients 
with and without AKI (Figure  2 ). The ratio between the con-
centration of NGAL and creatinine in urine samples signifi -
cantly increased after surgery (p < 0.001), peaking at 2-h and 
decreasing subsequently with a time course similar to that of 
uNGAL (Figure 2). 
 Considering all patients as a whole, BNP values increased 
after surgery [from 86 (40.8 – 216.8) ng/L before surgery to 
428.5 (271.0 – 891.0) ng/L at 12 h after surgery; p < 0.001], 
showing similar time-courses in patients with or without AKI. 
 Diagnostic accuracy of NGAL in the early diagnosis 
of AKI 
 uNGAL at 2 h showed a good diagnostic accuracy for the 
diagnosis of AKI, with an AUC of 0.85 (SE 0.034) with a cut-
off value of 49.95 ng/mL, a sensitivity 0.784 and a specifi city 
of 0.815. Data concerning the analysis of ROC curves, cor-
responding to samples, collected at different times throughout 
the study, are reported in Table  3 . 
 A signifi cant diagnostic accuracy for the presence of AKI 
was also found for BNP levels 12 h after surgery, with an 
AUC of 0.70 (sensitivity 0.712 and specifi city 0.612) with a 
best cut-off value of 423.5 ng/L. 
 Inter-relationships between biomarker values 
and clinical outcomes 
 A signifi cant negative correlation was found between uNGAL 
values and body surface area (BSA) ( ρ = – 0.23, p = 0.031). All 
uNGAL values observed after surgery positively correlated 
with the severity of the cardiac disease ( ρ = 0.26, p = 0.004 for 
uNGAL 2 h post-surgery), as assessed by pre-surgery BNP 
values, as well as with the indicators of surgery complex-
ity, as assessed by the Aristotle score ( ρ = 0.28, p = 0.001 for 
uNGAL 2 h post-surgery) and CPB-time ( ρ = 0.62, p < 0.001 
for uNGAL 2 h post-surgery). Highly signifi cant positive cor-
relations were also found between uNGAL values after sur-
gery and parameters of outcomes, such as intubation duration 
( ρ = 0.43, p < 0.001 for uNGAL 2 h post-surgery) and time spent 
in the ICU ( ρ = 0.46, p < 0.001 for uNGAL 2 h post-surgery). 
 Pre-surgery BNP values correlated negatively with BSA and 
age ( ρ = – 0.56, p < 0.001 and  ρ = – 0.51, p < 0.001, respectively), 
and positively with intubation duration ( ρ = 0.44, p < 0.001), 
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 Table 4  Logistic regression models for AKI. 
Univariable models
Variable, units OR (CI 95 % ) p-Value
Female vs. male 1.01 (0.50 – 2.03)    0.987
Body surface area, m 2 0.56 (0.36 – 0.86)    0.008
Older children vs. neonates 0.25 (0.10 – 0.62)    0.003
uNGAL pre-surgery, ng/mL a 1.07 (0.77 – 1.49)    0.677
uNGAL 2 h, ng/mL a 2.48 (1.81 – 3.40)  < 0.001
uNGAL 6 h, ng/mL a 2.40 (1.74 – 3.30)  < 0.001
uNGAL 12 h, ng/mL a 2.05 (1.53 – 2.75)  < 0.001
uNGAL peak, ng/mL a 2.85 (1.99 – 4.08)  < 0.001
uNGAL/urinary creatinine 
ratio pre-surgery a 
1.29 (0.97 – 1.72)    0.081
uNGAL/urinary creatinine 
ratio 2 h a 
1.87 (1.48 – 2.37)  < 0.001
uNGAL/urinary creatinine 
ratio 6 h a 
1.79 (1.42 – 2.25)  < 0.001
uNGAL/urinary creatinine 
ratio 12 h a 
1.85 (1.44 – 2.37)  < 0.001
BNP pre-surgery, ng/L a 1.44 (1.14 – 1.82)    0.002
BNP 12 h, ng/L a 2.18 (1.43 – 3.34)  < 0.001
CPB time, h 3.57 (2.01 – 6.33)  < 0.001
Cross-clamp, h 3.66 (1.80 – 7.46)  < 0.001
Intubation time, days 1.17 (1.04 – 1.31)    0.010
ICU stay, days 1.20 (1.07 – 1.35)    0.002
Aristotle score 1.55 (1.25 – 1.92)  < 0.001
Multivariable model
 AUC (SE) = 0.858 (0.040)
 uNGAL 2 h, ng/mL a 1.88 (1.30 – 2.72)    0.001
 CPB time, h 1.42 (0.75 – 2.69)    0.281
 Aristotle score 1.44 (1.05 – 1.99)   0.025
 ICU, intensive care unit.  a Log transformed variable. The uNGAL/
urinary creatinine ratio was calculated by the formula: ratio 
value = (uNGAL, expressed as ng/mL or μg/L)/(urinary creatinine, 
expressed as mg/dL) ×10. 
 Table 3  Data of ROC analysis. The values of best cut-off value, 
AUC, sensitivity and specifi city (calculated at the best cut-off) are 
reported. 
Data group uNGAL, 
ng/mL
AUC (SE) Sensitivity Specifi city
2 h post-surgery 49.95 0.85 (0.034) 0.784 0.815
6 h post-surgery 22.00 0.85 (0.036) 0.813 0.734
12 h post-surgery   3.55 0.78 (0.042) 0.766 0.610
Peak among 12 h 
post-surgery
64.75 0.87 (0.036) 0.824 0.802
 Peak within 12 h after surgery: the highest value measured within 
12 h after surgery. 
length of stay in the ICU ( ρ = 0.42, p < 0.001), and Aristotle 
score ( ρ = 0.24, p = 0.007). BNP values at 12 h after surgery 
were also signifi cantly correlated with 2 h uNGAL ( ρ = 0.321, 
p < 0.001), thus suggesting a link between cardiovascular and 
renal syndrome. Furthermore, BNP values at 12 h after sur-
gery correlated with arterial lactate ( ρ = 0.44, p < 0.001), left 
ventricular ejection fraction ( ρ = – 0.30, p = 0.007) and arterial 
blood pH ( ρ = 0.40, p = 0.002) at 12 h after surgery. 
 Logistic regression 
 Using a univariable logistic regression, all uNGAL and 
NGAL/creatinine ratio values after surgery were found to be 
signifi cantly associated with diagnosis of AKI, differently 
from the pre-operative values. The univariable analysis also 
indicated that BSA, Aristotle score, CPB time, and BNP were 
signifi cantly associated with the diagnosis of AKI (Table  4 ). 
Using a multivariate analysis, the uNGAL values at 2 h post-
surgery resulted independently associated with diagnosis 
of AKI, together with the CPB time and the Aristotle score 
(Table 4). 
 Univariable and multivariable Cox regression models 
 Univariable Cox models showed that higher Aristotle score 
and CPB time, but lower age and BSA, were signifi cantly 
associated with an increased risk of longer intubation times 
(Table  5 ). Lower pre-surgery urinary creatinine, higher pre-
operative and 12-h BNP and higher 2-h and peak uNGAL val-
ues moreover, were signifi cant predictor of longer intubation 
times. At multivariable analysis, Aristotle score, basal BNP 
and uNGAL at 2 h post-surgery remained the only signifi cant 
predictors of intubation time (Table 5). 
 Discussion 
 The principal aim of the present study was to evaluate whether 
the combined use of a cardio-specifi c biomarker, such as BNP 
 (27) , associated with a marker of early renal damage, such 
as uNGAL  (3, 12) , may provide a better risk stratifi cation in 
pediatric patients with congenital heart defects undergoing 
cardiac surgery. Another aim of this study was to evaluate 
whether the measurement of uNGAL and plasma BNP may 
signifi cantly and independently improve the diagnostic accu-
racy of AKI in these patients. 
 As far as the risk stratifi cation is concerned, the results 
of the present study demonstrate that uNGAL is strongly 
and independently associated with some adverse events in 
pediatric patients with congenital heart defects undergoing 
cardiac surgery (including the longer intubation time and the 
period of time spent in the ICU) (Table 5). Our study also 
indicates that the pre-operative BNP values were indepen-
dently associated with a more severe outcome in pediatric 
patients undergoing cardiac surgery. The results of our study 
therefore indicate for the fi rst time that the combined use of 
uNGAL and BNP can improve risk stratifi cation in pediat-
ric patients with congenital heart defects undergoing cardiac 
surgery. 
 As far as the diagnosis of AKI is concerned, a very 
recent study reported that plasma BNP is able to predict 
AKI in critically ill adult patients  (28) . In our clinical set-
ting, only uNGAL values after surgery, together with CPB 
time and the Aristotle score, resulted in independent predic-
tors of development of AKI syndrome, whereas BNP did 
not (Table 4). In particular, our results strongly support the 
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hypothesis that uNGAL may allow an early diagnosis of 
AKI in pediatric patients with congenital heart defects within 
6 h after cardiac surgery with a good diagnostic accuracy 
(Table 3). Taking into account that serum creatinine signifi -
cantly increases only 36 h after surgery (Figure 2), our fi nd-
ings suggest that uNGAL can allow a correct diagnosis in 
about 80 % of patients at least 1 day before than the serum 
creatinine. Confl icting results are reported in the literature 
about the diagnostic accuracy of NGAL as biomarker of 
AKI. Although the major part of studies  (4 – 7, 9) suggested 
that NGAL, measured in urine or blood samples, is a useful 
biomarker of AKI, other authors  (8) reported only a limited 
clinical value for plasma NGAL, assayed early after cardiac 
surgery in pediatric patients. However, Koch et al.  (8) used 
plasma (rather than urine) samples and a point-of-care testing 
(POCT) method for the assay of NGAL. This POCT method 
shows a lower analytical sensitivity as compared to the immu-
noassay method used in this present study  (18, 29) . It is theo-
retically conceivable moreover, that the assay of circulating 
levels of NGAL may be less accurate than its measurement in 
 Table 5  Cox models for time to extubation (TTE). 
Univariable models
Variable, units HR (CI 95 % ) p-Value
Female vs. male 1.25 (0.87 – 1.81)    0.229
Body surface area, m 2 1.76 (1.46 – 2.12)  < 0.001
Older children vs. neonates 2.49 (1.54 – 4.02)  < 0.001
Urinary creatinine pre-surgery, 
 mg/dL a 
1.41 (1.12 – 1.79)    0.004
Urinary creatinine 2 h, mg/dL a 1.39 (1.13 – 1.71)    0.002
Urinary creatinine peak, mg/dL a 1.73 (1.31 – 2.28)  < 0.001
Serum creatinine 12 h, mg/dL a 0.61 (0.45 – 0.84)    0.003
Serum creatinine peak, mg/dL a 0.58 (0.40 – 0.83)    0.003
uNGAL 2 h, ng/mL a 0.80 (0.72 – 0.89)  < 0.001
uNGAL 6 h, ng/mL a 0.72 (0.63 – 0.81)  < 0.001
uNGAL 12 h, ng/mL a 0.73 (0.64 – 0.83)  < 0.001
uNGAL peak, ng/mL a 0.74 (0.66 – 0.83)  < 0.001
uNGAL/creatinine ratio 
 pre-surgery a 
0.77 (0.66 – 0.9)    0.001
uNGAL/creatinine ratio 2 h a 0.76 (0.69 – 0.83)  < 0.001
uNGAL/creatinine ratio 6 h a 0.70 (0.63 – 0.78)  < 0.001
uNGAL/creatinine ratio 12 h a 0.71 (0.63 – 0.81)  < 0.001
uNGAL/creatinine ratio peak a 0.74 (0.67 – 0.82)  < 0.001
BNP pre-surgery, ng/L a 0.80 (0.70 – 0.91)    0.001
BNP 12 h, ng/L a 0.64 (0.52 – 0.78)  < 0.001
CPB time, h 0.76 (0.64 – 0.90)    0.001
Cross-clamp, h 0.61 (0.46 – 0.82)    0.001
ICU stay, days 0.40 (0.32 – 0.51)  < 0.001
Aristotle score 0.73 (0.67 – 0.81)  < 0.001
Multivariable model
 Aristotle score 0.76 (0.68 – 0.84)  < 0.001
 BNP pre-surgery, ng/ La 0.82 (0.71 – 0.94)    0.004
 uNGAL 2 h, ng/mL a 0.84 (0.75 – 0.94)    0.003
 HR < 1 suggested lower chance of extubation or conversely longer 
intubation time; HR < 1 suggested higher chance of extubation or 
equally lower intubation time; ICU, intensive care unit.  a Log trans-
formed variable. The uNGAL/urinary creatinine ratio was calculated 
by the formula: ratio value = (uNGAL, expressed as ng/mL or μg/L)/
(urinary creatinine, expressed as mg/dL) ×10. 
urine  (18) , even if the results of a recent meta-analysis were 
not able to confi rm this hypothesis  (19) . Finally, the indepen-
dent and signifi cant contribution of CPB time on the predic-
tion of the presence of AKI (Table 4) is largely expected when 
considering that CPB causes complex systemic infl ammatory 
responses that signifi cantly contribute to several adverse post-
operative complications, including renal damage  (30, 31) . 
 Study strengths and limitations of the present study 
 This study has several strengths. Firstly, we used a prospective 
cohort design and a rigorous protocol to collect specimens. 
Our study protocol furthermore, which used several sampling 
times, was able to clearly defi ne the time course of the bio-
markers. Finally, for the fi rst time, we evaluated together an 
early marker of renal damage (i.e., NGAL) and a marker of 
cardiac function (i.e., BNP) in order to test the hypothesis that 
the combined use of these two biomarkers could provide a 
better risk stratifi cation in pediatric patients with congenital 
heart defects undergoing cardiac surgery. 
 This study, however, does also have some limitations. 
Firstly, the total number of studied patients is relatively low. 
It is important however, to note that congenital heart defects, 
especially those with a more complex severe disease, are very 
rare (only about 1: 10,000 neonates present this disease)  (32) . 
It is consequently, very diffi cult to enrol a very large num-
ber of patients with congenital heart defects in a short time 
span. Another limitation is that our study considered outcome 
measures limited to the peri-operative period. Further studies 
with longer follow-up are needed to evaluate the long-term 
prognostic value of uNGAL. 
 Conclusions 
 The development of renal complications after cardiac surgery 
portends signifi cant morbidity and mortality  (33) . In particu-
lar, depending on the defi nition, post-operative AKI occurs 
in 3 % – 30 % of patients, with the need of renal replacement 
therapy in 1 % – 5 %  (33) . The prognosis among this subgroup 
of patients is poor, with an increased mortality risk exceed-
ing 60 % compared with the overall mortality rate of 2 % – 8 % 
after cardiac surgery  (33) . uNGAL after surgery moreover, 
(but not BNP) is a signifi cant and independent predictor for 
developing AKI. The measurement of uNGAL alone in par-
ticular, was able to allow a correct diagnosis of AKI in about 
80 % of patients at least 1 day before that of serum creatinine. 
Clinicians could use this gain in time to initiate an earlier and 
more appropriate treatment. 
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